Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
We describe a case of fulminant onset, rapidly progressive-interstitial lung disease (RP-ILD) with anti-ARS antibodies (anti-PL-7). The patient was successfully treated with nintedanib in addition to intensive immunosuppressive therapies, including intravenous cyclophosphamide. Nintedanib has just b...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2020-01-01
|
| Seri Bilgileri: | Respiratory Medicine Case Reports |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S221300712030486X |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|